Introduction and aim of study: there is recent evidence that the immune sys
tem plays an essential role in the pathogenesis of atherosclerosis, with bo
th cellular and humoral mechanisms being involved. Heat-shock proteins (HSP
s) have been detected in atherosclerotic lesions, and antibodies to HSPs ha
ve also been found to be raised in patients with carotid stenoses. The aim
of our study was to examine the level of anti-HSP70 antibodies in patients
with other vascular diseases.
Materials and methods: a questionnaire was designed for Ale subjects in the
study, with documentation of clinical details and ankle-brachial pressure
index. Patients with concomitant infection, malignancy, hepatorenal failure
, or recent surgery were excluded. Enzyme-linked immunosorbent assay (ELISA
) was used to identify anti-HSP70 antibodies in the sera in different dilut
ions. Graphs of optical density (OD) vs, negative log dilution were plotted
, the gradient of which teas taken to be the estimated optical density for
each subject (proportional to antibody level). Our groups consisted of cont
rols (n = 21, mean age 59.0 +/- 19.2), lower limb claudicants ((n = 19, mea
n age 60.0 +/- 12.6), patients with lower-limb critical ischaemia (n = 22,
mean age 68.5 +/- 10.07), and patients with abdominal aortic aneurysms (n =
20, mean age 69.9 +/- 6.2).
Results: we found no correlation between age and the estimated OD in our su
bjects (Spearman's correlation coefficient (r) = 0.123, one-railed p value
was 0.135). Patients with intermittent claudication, critical lower limb is
chaemia, and aneurysms had higher Estimated OD, and therefore higher anti-H
SP70 antibody levels, than controls (Mann-Whitney test; p = 0.0127, 0.0037,
0.0008, respectively).
Conclusions: our data provide the first evidence of a correlation between a
nti-HSP70 antibodies and different types of vascular diseases, suggesting t
hat HSP70 might be involved in the pathogenesis and propagation of atherosc
lerosis. Since the immune response to HSPs can be modulated, this opens lip
the possibility of new therapeutic approaches.